It'll be two years next week when I first bought Rbiz shares, so I've seen the company grow dramatically and then stumble almost as much. CBD play is interesting, but the company still needs to find a way back to better funding. No way to sugarcoat 2020 after all the progress of 2019.
Now stock comp is done, it's up to Anshu to show he can protect shareholder value while growing the company. I still think the gummies are a long-term winner, and he was adamant the PPE play was already smart deal, delivering $820K on $100K upfront. But company has to get free of diluting notes.